Treatment of Nicotinamide Phosphoribosyltransferase (NAMPT) related diseases by inhibition of natural antisense transcript to NAMPT
TW201209163A
Treatment of BCL2 binding component 3 (BBC3) related diseases by inhibition of natural antisense transcript to BBC3
WO2011163499A2
Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
CN102971423A
Treatment of methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA
TW201143782A
Treatment of LIM homeobox 2 (LHX2) related diseases by inhibition of natural antisense transcript to LHX2
WO2011031482A2
Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
CA2770104A1
Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
KR20120029474A
Ttreatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
WO2010138806A2
Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
CA2761142A1
Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
CA2761152A1
Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
CN102639151A
Treatment of hemoglobin (HBF/HBG) related diseases inhibition of natural antisense transcript to HBF/HBG
CA2754749A1
Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
MX2011005912A
Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf.
